Search

The article discusses the 2016 survey conducted by "Chemical & Engineering News" journal into the research and development (R&D) spending of U.S. and European chemical manufacturers. Topics explored include the allotment of budget for R&D by survey respondents, the percentage of chemical firms surveyed that expressed plans to invest in capital projects, and brief details about the R&D spending of companies such as Dow Chemical, Eastman Chemical, and Clariant from 2010 to 2015.

Several charts and diagrams are presented depicting spending for research and development in the U.S. higher education research institutions including California Institute of Technology, University of Michigan and University of Minnesota.

The article focuses on China competing with U.S. to capture its place as a leader in science and engineering related research & development (R&D) investments. It discusses China is trying expand its technology capabilities with a sustained growth rate while U.S. averages a lower growth rate due to decreasing federal funding for U.S. research.

The article presents the policy statements issued by the American Chemical Society (ACS) as of January 2016. The ACS endorses an energy policy that prioritizes energy efficiency and encourages legislators to restore investments in federal research and development (R&D) funding. The organization also supports investments in business innovations and entrepreneurship.

The article provides an outlook for regulations in the chemical science enterprise in the U.S. in 2016. Observers believe that Congress will not introduce new regulations because of the November 2016 general election. Also presented are research and development budgets for several science funding agencies during the year.

The article reports on the 2016 research and development budget proposal of the U.S. government introduced by President Barack Obama on February 2, 2015 which calls for ambitious spending increases for science and technology. The budget proposal includes increases for the Defense, Energy and Health & Human Services Departments but cuts for the Homeland Security. Other agencies that saw budget increase include the National Institutes of Health, the National Science Foundation and Commerce.

The article reports on an increase in federal funding for the U.S. National Institute of Standards & Technology (NIST) and the National Oceanic & Atmospheric Administration (NOAA) under the proposed fiscal 2013 budget. It notes that almost half of the NIST's 14.1% rise in budget would be aimed at supporting efforts in promoting emerging manufacturing challenges in new technology areas. NOAA would receive a 3.1% increase in funding but its overall research and development budget drops by 3.8%.

The article reports on the 24.4% increase in federal funding for the U.S. Department of Homeland Security (DHS) Science & Technology Directorate (S&T) under the proposed fiscal 2013 budget. S&T is expected to spend 478 million U.S. dollars on various research and development programs such as biological defense and cybersecurity. A recommendation was issued by the administration of President Barack Obama not to provide new funding for the construction of a biosecurity research lab in Kansas.

The article reports on the 3.2% increase in federal funding for the U.S. Department of Energy (DOE) under the proposed fiscal 2013 budget. According to Energy Secretary Steven Chu, a focus on clean and renewable energy research and development (R&D) is one of the underlying themes of the budget proposal. For overall R&D funding, the DOE is seeking 10.3 billion U.S. dollars. The Advanced Research Projects Agency-Energy program is facing a 27.3% increase in budget.

The article reports on the plan of Bayer CropScience to phase out some older products, increase research and development (R&D) spending, and extend its seed business.

The article reports on the increase in U.S. companies' investment in research and development in 2014, according to data released by the National Science Foundation.

The article reports on the research and development (R&D) funding made by German specialty chemical firm Evonik Industries in 2015.

The article reveals the increase in U.S. federal research and development (R&D) funding in 2014 compared in 2013, according to data released by the National Science Foundation (NSF).

A letter to the editor is presented in response to the article on funding research and development (R&D) for treatment of myalgic encephalomyelitis on the August 3, 2015 issue.

The article focuses on increase in business spending on research and development (R&D) in the U.S. in 2013 as per a report from the U.S. National Science Foundation and mentions highest R&D spending in the pharmaceutical production and increase in payments for chemical research at U.S. companies.

The article reports on the budget increase for research and development of the U.S. Energy Department for 2016 as outlined in the budget proposal of President Barack Obama on February 2, 2015.

The article reports that Bayer AG, a chemical and pharmaceutical company, expects 4.4 billion dollars on research and development (R&D) activities in 2014 and mentions that Bayer Healthcare accounts for 70 percent of R&D spending.

The article focuses on a report by the National Science Foundation of the U.S. which shows that allocation for federal research and development (R&D) spending by the U.S. Congress has been increased by 2.4 percent in fiscal 2014 to 136 million dollars as compared with the previous fiscal year.

The article reports on funding from CoorsTek, ceramics firm, and the Coors family to the Colorado School of Mines for development of a science and engineering center for Applied Science & Engineering on the school's campus in Golden, Colorado.

The article reports on the plans of chemical maker BASF SE to raise its research spending outside Europe so it accounts for half of the total spending on research and development (R&D) by 2020.

The article reflects on a 3.9 trillion U.S. dollars fiscal 2015 budget request proposed by U.S. President Barack Obama on March 4, 2014. It mentions that the request would provide 135.4 billion U.S. dollars for research and development (R&D) activities including 64.7 billion U.S. dollars for basic and applied research. Further it informs about a proposal by Obama for a 56 billion U.S. dollars Growth & Security Initiative (OGSI).

The article informs that U.S. President Barack Obama offered a series of small steps during the State of the Union address in the U.S. on January 28, 2014 which can help to spur the growth of technologies in the U.S. chemical industry and increase research and development (R&D) spending. Topics discussed include the creation of manufacturing innovation institutes, Obama urged the U.S. Congress to give his administration authority in trade deals and Obama discussed patent reform.

The article discusses the single digit growth in analytical life sciences instrumentation companies due to less expenditure in research and development fields in the U.S. which has triggered several firms to announce merger and acquisition activity.

The article states that with reduced funds for research and development activities during 2014 pharmaceutical companies will relay on academia and biotech firms for introducing new drugs and medicines.

The article discusses the research funding for biomedical research and development related activities in the U.S. It informs that according to a study published in the New England Journal of Medicine the share of U.S. declined from 50 percent in 2007 to 45 percent in 2012 and the share of China increased by four times during the same period. Views of G. Steven Burrill, head of the health care investment firm Burrill & Co., on the issue is also presented.

The article informs that BASF SE, a chemical firm, is planning to provide its 25 percent of research and development (R&D) budget into researches related to chemistry carried out by researchers in North America and Asia. It mentions that the company will open a laboratory in Wyandotte, Michigan for producing thermoplastic polyurethanes and it will also develop lightweight materials for wind turbine applications.

The article informs that Great Britain-based pharmaceutical company GlaxoSmithKline (GSK) has announced that it will provide support and one million U.S. dollars funds to laboratories for doing research in the field of electroceuticals. According to Kristoffer Famm, GSK vice president of bioelectronics research and development (R&D), GSK believes that manipulating neural signals can be beneficial for medical therapeutics so GSK has decided to fund researchers working in electroceuticals.

The article focuses on the 2014 federal budget plan proposed by U.S. President Barack Obama. According to the proposed budget plan, Obama has increased the budget for the National Science Foundation (NSF) by 8.4 percent and budget for the U.S. Department of Energy (DOE) Office of Science has been increased by 4.4 percent. It further mentions that the budget plan also include 379 million U.S. dollars for the Advanced Research Projects Agency-Energy of DOE.

The article informs that the spending in the field of research and development by the U.S. Universities has increased to 65.1 billion U.S. dollar in 2011.

The article reports on the 4.4% decline in federal funding for the U.S. Defense Department (DOD) under the proposed fiscal 2013 budget. For early-stage science and technology programs, DOD has requested 11.9 billion U.S. dollars in funding. Some of the high-priority areas of DOD research and development (R&D) include cybersecurity, robotics, and energy efficiency. Both applied research and advanced technology development programs would face a drop in funding.

The article reports on the 1.7% increase in federal funding for the U.S. Environmental Protection Agency's (EPA) science and technology efforts under the proposed fiscal 2013 budget. According to Administrator Lisa P. Jackson, science is still the foundation of the EPA's work. A 14 million U.S. dollar budget to study the safety of hydraulic fracturing is included in the proposal. Some research efforts at EPA will be eliminated due to budget cuts including the clean car technology effort.

The article discusses the budget proposed by U.S. President Barack Obama for federal research and development (R&D) in 2012. The 2013 budget request has allocated 140.8 billion U.S. dollars for federal R&D, representing a 1.4% rise over the 2012 budget. Some of the administration's priorities for its support of R&D include to support U.S. jobs through advanced manufacturing R&D and ensuring effective science, technology, engineering and mathematics (STEM) education.

The article reports on the budget request by U.S. President Barack Obama for federal research and development (R&D) in his fiscal 2013 budget, which was launched on February 13, 2012. The total R&D budget is 2.0 billion U.S. dollars. Obama said that the budget is a reflection of shared responsibility. The budget request raised the overall funding of the National Science Foundation (NSF), the National Institute of Standards and Technology (NIST), and the Department of Energy's Office of Science.

The article announces the investment plans of European firms Evonik Industries, Arkema and Badische Anilin und Soda Fabrik (BASF) in China's chemical production research and development (R&D). Evonik's plans include the building of an isophorone and isophorone diamine plant in Shanghai's Xinzhuang district while Arkema is set to build its R&D center in Changshu. BASF eyes the construction of a tert-butylamine plant in Nanjiing with an annual production capacity of 10,000 metric tons.

The article reports on the Living Foundries program by the U.S. Defense Advanced Research Projects Agency (DARPA) as of July 2011 that would finance high-risk, cutting-edge research & development (R&D) in synthetic biology.

The article reports on the move of GlaxoSmithKline and MaRS Innovation to launch a fund devoted to pulling research out of 16 Canadian academic institutions and hospitals.